首页> 外文OA文献 >PND16 A RETROSPECTIVE CLAIMS ANALYSIS OF US HEALTH PLAN COMMERCIAL INSURANCE DATA ASSESSING HEALTHCARE COSTS AND RELAPSE RATES IN MULTIPLE SCLEROSIS PATIENTS TREATED WITH GENERIC GLATIRAMER ACETATE

【2h】

PND16 A RETROSPECTIVE CLAIMS ANALYSIS OF US HEALTH PLAN COMMERCIAL INSURANCE DATA ASSESSING HEALTHCARE COSTS AND RELAPSE RATES IN MULTIPLE SCLEROSIS PATIENTS TREATED WITH GENERIC GLATIRAMER ACETATE

机译：PND16对美国健康计划商业保险数据的回顾性声明分析评估用通用Glativer醋酸酯治疗的多发性硬化症患者的医疗费用和复发率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
B. Greenberg; M. Grabner; X. Zhang; S. Balu; S. Hall; D. Kantor;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: A retrospective US claims database analysis [J] . BergvallN., MakinC., LahozR., Current medical research and opinion . 2013,第12期

机译：芬戈莫德与干扰素或醋酸格拉替雷对多发性硬化症复发率的比较有效性：美国一项回顾性索赔数据库分析
2. Healthcare resource use and relapses with fingolimod versus natalizumab for treating multiple sclerosis: a retrospective US claims database analysis [J] . Bergvall Niklas, Lahoz Raquel, Reynolds Tracy, Current medical research and opinion . 2014,第8期

机译：芬戈莫德和那他珠单抗治疗多发性硬化症的医疗资源使用和复发：美国一项回顾性索赔数据库分析
3. Treatment Duration, Healthcare Resource Utilization, and Costs Among Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis [J] . Schultz Neil M., Flanders Scott C., Wilson Samuel, Advances in therapy. . 2018,第10期

机译：治疗持续时间，医疗资源利用率和化疗 - 天真患者的转移性阉割前列腺癌患者的成本，用乙醛胺或醋酸盐酸酯治疗：回顾性要求分析
4. Data normalization and supervised learning to assess the condition of patients with multiple sclerosis based on gait analysis [C] . Samir Azrour, Sebastien Pierard, Pierre Geurts, European symposium on artificial neural networks, computational intelligence and machine learning . 2014

机译：基于步态分析的数据标准化和监督学习以评估多发性硬化症患者的状况
5. The Impact of Health Insurance Status on Healthcare Resource Utilization and Out-of-Pocket Costs in Patients with Multiple Sclerosis in the U.S.A [D] . Elsisi, Zizi. 2020

机译：健康保险状况对患有多发性硬化患者的医疗资源利用和U.S.A的患者的影响
6. Comparison of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of Healthcare Resource Utilization and Relapse Rates from US Insurance Claims Data [O] . Jacqueline Nicholas, Aaron Boster, Ning Wu, 2018

机译：用于多发性硬化症治疗的疾病改良疗法的比较：根据美国保险理赔数据分析医疗保健资源的利用率和复发率
7. Recent transition of medical cost and relapse rate of multiple sclerosis in Japan based on analysis of a health insurance claims database [O] . Izumi Kawachi, Shuichi Okamoto, Mariko Sakamoto, 2019

机译：基于健康保险索赔数据库的分析，日本多发性硬化的医疗成本和复发率的最近过渡

PND16 A RETROSPECTIVE CLAIMS ANALYSIS OF US HEALTH PLAN COMMERCIAL INSURANCE DATA ASSESSING HEALTHCARE COSTS AND RELAPSE RATES IN MULTIPLE SCLEROSIS PATIENTS TREATED WITH GENERIC GLATIRAMER ACETATE

著录项

引文网络

相似文献

相关主题

期刊订阅